Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: MINISTRY OF DEFENCE
Awarding agency: Department of Defense / Defense Contract Management Agency
Funding agency: Department of Defense / Defense Threat Reduction Agency
Period of performance: 2024-06-10 to 2027-06-08
Current total value of award: $5630590.98
Description: UNDEFINITIZED ORDER THURST 7 -GENERATION OF NOVEL ANTIBODY - ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIODOSIS